News

SAN DIEGO, March 18, 2025--Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today ...
Telesis Bio, Inc. (NASDAQ:TBIO) shares are moving higher on Thursday after the company announced a partnership with Beckman Coulter Life Sciences. The partnership integrates Telesis Bio’s Gibson ...
Short interest in Telesis Bio Inc (OTC:TBIO) increased during the last reporting period, rising from 1.58K to 9.95K. This put 2.43% of the company's publicly available shares short. Short interest ...
SAN DIEGO, March 18, 2025--(BUSINESS WIRE)--Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated ...
Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis Telesis Bio, a leading provider of DNA and mRNA synthesis ...